Journal
DIABETES CARE
Volume 37, Issue 9, Pages 2593-2600Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc14-0065
Keywords
-
Categories
Funding
- Folkhalsan Research Foundation
- Academy of Finland [134379]
- Helsinki University Central Hospital Research Funds (EVO)
- Wilhelm and Else Stockmann Foundation
- Waldemar von Frenckell Foundation
- Liv och Halsa Foundation
- Finnish Medical Society (Finska Lakaresallskapet)
- Diabetes Research Foundation
- Nylands Nation Foundation
- Paulo Foundation
- Paavo Nurmi Foundation
- Finnish Medical Foundation
- Biomedicum Helsinki Foundation
- Academy of Finland (AKA) [134379, 134379] Funding Source: Academy of Finland (AKA)
Ask authors/readers for more resources
OBJECTIVE Osteopontin (OPN) is a multifunctional protein suggested to be a player in the arterial disease of patients with type 2 diabetes. However, its role for complications in patients with type 1 diabetes (T1D) is unknown. We therefore investigated the associations between OPN and diabetic vascular complications and all-cause mortality in patients with T1D. RESEARCH DESIGN AND METHODS Serum OPN was measured in 2,145 adults with T1D without end-stage renal disease (ESRD; dialysis or transplantation) as part of the Finnish Diabetic Nephropathy (FinnDiane) Study. Data on renal status, cardiovascular disease (CVD), and all-cause mortality during follow-up were verified from medical files, hospital discharge registries, and the Finnish National Death Registry, respectively. The median follow-up time was 10.5 (interquartile range 8.9-11.8) years. RESULTS Serum OPN was higher at baseline in patients who developed incident microalbuminuria (16.0 +/- 0.9 vs. 14.1 +/- 0.2 mg/L; P = 0.04), progressed to ESRD (28.3 +/- 1.7 vs. 15.4 +/- 0.2 mg/L; P < 0.001), suffered an incident CVD event (20.2 +/- 1.2 vs. 15.5 +/- 0.2 mg/L; P < 0.001), or died (23.3 +/- 1.4 vs. 15.8 +/- 0.2 mg/L; P < 0.001) during follow-up. In multivariate Cox regression analysis, OPN was independently associated with the development of incident microalbuminuria, an incident CVD event, and death, after adjustments for associated risk factors. Even after calculating reclassification indexes, OPN was predictive of CVD and all-cause mortality beyond the Framingham risk score covariates and hs-CRP. CONCLUSIONS Serum OPN is a strong predictor of incipient diabetic nephropathy, a first-ever CVD event, and all-cause mortality in patients with T1D. Serum OPN may be of clinical significance for the risk prediction of CVD events in patients with T1D.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available